Female pattern hair loss
- PMID: 30114864
- DOI: 10.31128/AJGP-02-18-4498
Female pattern hair loss
Abstract
Background: Female pattern hair loss (FPHL) is a commonly encountered clinical presentation in primary care. Patterned hair loss in women is characterised by diffuse hair thinning and often becomes an ongoing cause of psychosocial distress.
Objective: The aim of this article is to present a practical approach for the clinical assessment of female hair loss and to review the up-to-date treatment modalities.
Discussion: Alopecia can be the first symptom of systemic illness. It is therefore crucial for the primary care physician to be able to differentiate between FPHL and more concerning causes of hair loss. Treatment options often involve a combination of non-androgenic and androgenic therapy. The use of oral minoxidil in combination with oral spironolactone is a novel therapy with promising results. The role of the general practitioner is paramount in establishing the diagnosis, setting achievable therapeutic goals and navigating the psychosocial comorbidity associated with this chronic condition.
Similar articles
-
Female pattern hair loss.Curr Probl Dermatol. 2015;47:45-54. doi: 10.1159/000369404. Epub 2015 Feb 20. Curr Probl Dermatol. 2015. PMID: 26370643 Review.
-
Efficacy of Topical Combination of 0.25% Finasteride and 3% Minoxidil Versus 3% Minoxidil Solution in Female Pattern Hair Loss: A Randomized, Double-Blind, Controlled Study.Am J Clin Dermatol. 2019 Feb;20(1):147-153. doi: 10.1007/s40257-018-0387-0. Am J Clin Dermatol. 2019. PMID: 30206824 Clinical Trial.
-
Female Pattern Hair Loss and Androgen Excess: A Report From the Multidisciplinary Androgen Excess and PCOS Committee.J Clin Endocrinol Metab. 2019 Jul 1;104(7):2875-2891. doi: 10.1210/jc.2018-02548. J Clin Endocrinol Metab. 2019. PMID: 30785992
-
Female pattern hair loss: a pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone.Int J Dermatol. 2018 Jan;57(1):104-109. doi: 10.1111/ijd.13838. Epub 2017 Dec 12. Int J Dermatol. 2018. PMID: 29231239
-
Hair loss in women: medical and cosmetic approaches to increase scalp hair fullness.Br J Dermatol. 2011 Dec;165 Suppl 3:12-8. doi: 10.1111/j.1365-2133.2011.10630.x. Br J Dermatol. 2011. PMID: 22171680 Review.
Cited by
-
The Predictive Value of Midscalp Hair Density and Terminal Hair Percentage in the Severity Evaluation of FPHL Assessed by Trichoscan in a Sample of Chinese Population.Clin Cosmet Investig Dermatol. 2022 Dec 13;15:2675-2684. doi: 10.2147/CCID.S390148. eCollection 2022. Clin Cosmet Investig Dermatol. 2022. PMID: 36536758 Free PMC article.
-
Age-Related Macular Degeneration in Patients with Androgenetic Alopecia: Could the Monocyte/HDL Ratio Be the Link?Dermatol Pract Concept. 2023 Oct 1;13(4):e2023285. doi: 10.5826/dpc.1304a285. Dermatol Pract Concept. 2023. PMID: 37992380 Free PMC article.
-
Frontal Fibrosing Alopecia and Reproductive Health: Assessing the Role of Sex Hormones in Disease Development.J Pers Med. 2024 Jan 5;14(1):72. doi: 10.3390/jpm14010072. J Pers Med. 2024. PMID: 38248773 Free PMC article. Review.
-
Female Pattern Hair Loss and Negative Psychological Impact: Possible Role of Brain-derived Neurotrophic Factor (BDNF).Dermatol Pract Concept. 2023 Jul 1;13(3):e2023139. doi: 10.5826/dpc.1303a139. Dermatol Pract Concept. 2023. PMID: 37557155 Free PMC article.
-
Male and female pattern hair loss.Aust Prescr. 2025 Jun;48(3):93-97. doi: 10.18773/austprescr.2025.020. Aust Prescr. 2025. PMID: 40568688 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources